Lombard Medical Technologies (NSDQ:EVAR) said this month that its CEO Simon Hubbert and CFO William Kullback are stepping down from their positions, with Kurt Lemvigh stepping into the CEO role. Hubbert served as CEO for 6 years after joining the company in 2010, and will be replaced by Lemvigh, who has held positions with multiple companies, including […]
ReWalk Robotics
ReWalk Robotics slides on Barclays downgrade
Shares in ReWalk Robotics (NSDQ:RWLK) are off nearly 4% today after an analyst with Barclays downgraded the stock, citing “lack of tangible progress” and increased competition from other players in the robot-assisted rehabilitation market. Barclays analyst Matthew Taylor lowered the investment house’s rating on ReWalk from “equal weight” to “underweight” and cut his price target to […]
RTI Surgical names new CEO, parts ways with CSO Hartill | Personnel Moves | January 31, 2017
RTI Surgical (NSDQ:RTIX) named Camille Farhat as its chief executive officer, effective March 15, 2017. Previously, Farhat served as president & CEO of American Medical Systems, Inc., where he helped facilitate Boston Scientific (NYSE:BSX)’s $1.65 billion acquisition of the men’s and prostate health businesses. He has also held leadership positions with Baxter (NYSE:BAX), Medtronic (NYSE:MDT) and General Electric (NYSE:GE). “Today […]
Layoffs ahead for ReWalk Robotics
ReWalk Robotics (NSDQ:RWLK) is reportedly planning to cut its operating expenses by 30% in 2017, a move that’s slated to include layoffs for an unspecified number of workers. The Marlborough, Mass.- and Israel-based company said it aims to meet its goal partially via a “reduction in staffing.” ReWalk had 87 employees as of December 2015, according to […]
ReWalk Robotics raises $12m, forecasts Q3 sales beat
ReWalk Robotics (NSDQ:RWLK) last week priced a stock-and-warrants offering worth more than $12 million and said it expects its 3rd-quarter earnings to beat expectations on Wall Street. Yokneam, Israel- and Marlborough, Mass.-based ReWalk, which makes a robotic exoskeleton designed to assist patients with spinal cord injuries, said it floated 3.25 million units at $3.75 apiece […]
ReWalk inks collab deal with Harvard to develop “soft” exosuit
ReWalk Robotics (NSDQ:RWLK) said today it inked a collaborative research with Harvard’s Wyss Institute to develop a lightweight “soft suit” exoskeleton system for lower limb disabilities. The collaboration looks to design a suit to treat stroke, multiple sclerosis and mobility limitations for the elderly as well as other applications. Through the agreement, ReWalk will pay Harvard […]
ReWalk Robotics touts reimbursement win for powered exoskeleton
ReWalk Robotics (NSDQ:RWLK) said today it won reimbursement coverage through a commercial health insurance plan which made changes to include powered exoskeletons for ambulation in patients with lower limb disabilities. ReWalk develops and produces exoskeletons designed to restore self-initiated walking for patients with spinal cord injuries. The personal system is battery-powered and features an array of sensors […]
Sorrento lures ex-Hologic exec Herde | Personnel Moves April 7, 2016
FDA warns ReWalk on lack of post-market surveillance for exoskeleton
The FDA today released a warning letter it sent to ReWalk Robotics (NSDQ:RWLK), formerly Argo Medical, over a failure to submit a post-market surveillance report on its ReWalk exoskeleton device addressing issues with injuries during falls while operating the device. The agency detailed a string of back-and-forth communications between it and the ReWalk maker going […]
ReWalk chalks up reimbursement win for exoskeleton system
ReWalk Robotics (NSDQ:RWLK) said today it won coverage and reimbursement for its ReWalk Personal exoskeleton systems from a commercial health plan in the Northwest region of the U.S. The approval was made following the ruling of an independent review organization that overturned an initial denial of coverage. The Israeli comapny said the beneficiary in the […]
VA to launch trial of ReWalk’s exoskeleton system
ReWalk Robotics (NSDQ:RWLK) said today that the Department of Veterans Affairs released details of a planned 4-year, national, multi-center study of ReWalk’s Personal 6.0 exoskeleton systems. The aptly named Exoskeleton Assisted-Walking in Persons with SCI: Impact on Quality of Life study is slated to enroll 160 patients at 6 participating VA Medical Centers across California, Florida, Massachusetts, […]